Mitchell Duffy has a diverse work experience in various fields.
Starting from 2010, Duffy worked as an Automation Intern at Omeros Corporation, where they integrated a High Throughput Screening Automation System and developed an optimized ELISA based Assay. Mitchell also created an in-house database and GUI for experimental data and literature information.
In 2012, Duffy served as a Computational Science Intern at MIT Lincoln Laboratory.
From 2013 to 2018, Duffy worked as a Doctoral Researcher at UKM Uniklinikum Muenster, focusing on collagen degrading enzymes in Arthritis and implementing photoacoustic imaging systems.
In 2019, Duffy joined Entrepreneur First as a member of the EF BE3 Cohort, where they worked on ideas in synthetic biology and provided business development support to fledgling companies.
Also in 2019, Duffy became an Entrepreneur in Residence at Merantix, where they ideated and derisked venture cases at the intersection of synthetic biology and machine learning, with a focus on healthcare and bioindustrial applications.
Their most recent role was Chief Executive Officer at Cambrium, a next-generation materials company. In this role, Duffy led a team of business strategists, materials scientists, molecular biologists, and machine learning specialists to reimagine everyday products by utilizing the molecular programmability of proteins.
Overall, Duffy's work experience demonstrates their expertise in various fields, including automation, computational science, bio-imaging, synthetic biology, and machine learning.
Mitchell Duffy started their education in 2008 at Tufts University, where they pursued a Bachelor of Science (BS) in Biology and Computer Science. Mitchell completed this degree in 2012. In that same period, Mitchell also earned another Bachelor of Science (BS) degree from Tufts University, this time in Computer Science.
In 2010 to 2011, Mitchell attended UCL, where they studied Biology and Computer Science, although the specific degree earned during this time is not mentioned.
Following their undergraduate studies, Mitchell Duffy pursued a Master of Research degree in Systems and Synthetic Biology at Imperial College London, which they completed in 2013.
Lastly, from 2013 to 2018, Mitchell Duffy attended the University of Münster, where they obtained a Doctor of Philosophy (PhD) degree in Molecular Imaging.
Overall, Mitchell Duffy demonstrated a strong educational background with degrees spanning Biology, Computer Science, Systems and Synthetic Biology, and Molecular Imaging, reflecting their diverse academic interests.
August, 2020 - present